Drugs References Warning Labels Now Added to Prostate Cancer Medication

Drugs References The FDA has decided to add drugs references warning labels that detail the potential risks of heart disease and diabetes to patients who use prostate cancer gonadotropin-releasing hormone (GnRH) agonists. In addition to the drug’s generic classification, GnRH drugs are sold as brand names Eligard,, Lupron, Synarel, Trelstar, Vantas, and Zoladex in the U.S

Read more

Thu, 10/21/2010 - 04:58